Cormedix Inc. (NASDAQ:CRMD)

CorMedix Inc., a development stage pharmaceutical and medical device company, focuses on developing and commercializing therapeutic products for the treatment of cardiac and renal dysfunction, primarily in the dialysis and non-dialysis areas. The company’s principal product under development includes CRMD003 (Neutrolin) for the prevention of catheter related bloodstream infections and maintenance of catheter patency in central venous catheters used for vascular access in hemodialysis patients. Its products also include CRMD004, a pressure sensitive gel that is in pre-clinical Phase. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.

Last updated March 6, 2013